| Bioactivity | Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib has the potential for cancer study. |
| Name | Cinsebrutinib |
| CAS | 2724962-58-5 |
| Formula | C22H26FN3O2 |
| Molar Mass | 383.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Coburn, Craig Alan, et al. Preparation of pyridoindolecarboxamides and their analogs as BTK kinase inhibitors. WO2021207549. |
Cinsebrutinib
CAS: 2724962-58-5 F: C22H26FN3O2 W: 383.46
Cinsebrutinib is a Bruton's tyrosine kinase inhibitor, extracted from patent WO2021207549 (compound 5-6). Cinsebrutinib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.